Analyst Price Targets — ASTH
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 2, 2026 12:14 pm | — | BTIG | $40.00 | $22.74 | TheFly | Astrana Health price target lowered to $40 from $45 at BTIG |
| December 12, 2025 11:23 am | Matthew Shea | Needham | $28.00 | $22.46 | TheFly | Astrana Health initiated with a Buy at Needham |
| November 25, 2025 4:33 pm | — | Jefferies | $37.00 | $22.91 | TheFly | Astrana Health price target lowered to $37 from $44 at Jefferies |
| November 24, 2025 11:21 am | Andrew Mok | Barclays | $26.00 | $22.50 | TheFly | Astrana Health price target lowered to $26 from $36 at Barclays |
| April 1, 2025 11:26 am | — | Barclays | $36.00 | $29.86 | TheFly | Astrana Health initiated with an Equal Weight at Barclays |
| March 3, 2025 12:00 pm | — | Robert W. Baird | $50.00 | $26.48 | TheFly | Astrana Health price target lowered to $50 from $86 at Baird |
| October 3, 2024 7:22 am | David Larsen | BTIG | $70.00 | $57.87 | TheFly | Astrana Health price target raised to $70 from $60 at BTIG |
| August 15, 2024 6:34 am | Michael Ha | Robert W. Baird | $67.00 | $46.58 | TheFly | Astrana Health price target raised to $67 from $54 at Baird |
| June 27, 2024 8:09 am | Chris O'Cull | Stifel Nicolaus | $48.00 | $40.50 | StreetInsider | Astrana Health, Inc (ASTH) PT Raised to $48 at Stifel |
Latest News for ASTH
Company to Host Conference Call on Monday, March 2, 2026, at 5:30 a.m. PT/8:30 a.m.
Astrana Health (NASDAQ: ASTH - Get Free Report) and Super Nova Resources (OTCMKTS:SNRR - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, valuation, risk, institutional ownership, analyst recommendations, earnings and profitability. Institutional and Insider Ownership 52.8% of Astrana
Super Nova Resources (OTCMKTS:SNRR - Get Free Report) and Astrana Health (NASDAQ: ASTH - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, analyst recommendations and dividends. Institutional and Insider Ownership 52.8% of Astrana
Astrana Health Inc. (NASDAQ: ASTH) stock on Tuesday fell around 22% to close at $21.48.
ALHAMBRA, Calif., Jan. 26, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the fourth quarter and year ended…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ASTH.
U.S. House Trading
No House trades found for ASTH.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.